Eve Taylor

VP, Clinical Development at Engrail Therapeutics

Eve has over 20 years of industry experience with specific focus on neuroscience clinical development and operations. Most recently, Eve helped lead early stage clinical development at Intra-Cellular Therapies. Previously, Eve led clinical development activities at Cytori Therapeutics, Ceregene and ACADIA Pharmaceuticals. Eve has also served as founder and lead at Taylored BioConsulting, providing clinical development and other consulting services. Eve received her BSc (Hons) from University of Western Australia, PhD in Biochemistry from King’s College London and completed her post-doctoral training at the Salk Institute for Biological Studies and University of California – San Diego.

Links


Org chart


Teams


Offices

This person is not in any offices


Engrail Therapeutics

Transforming the lives of patients with life-limiting diseases of the nervous system. Acquiring, developing and commercializing transformative medicines.


Employees

11-50

Links